Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
Even though the Environmental Protection Agency (EPA) announced there’s no link between Roundup and cancer, the Center for Food Safety has faulted the decision.
“EPA’s announcement that it has concluded its regulatory review of glyphosate is false,” according to Ryan Talbott, staff attorney at the Center for Food Safety in a press release. “The truth is that after a decade of review, the EPA still has not conducted the necessary research on glyphosate’s impacts on human health and threatened and endangered species.”
Talbott faulted the EPA for relying on studies funded by Monsanto and not paying attention to independent studies that have found Roundup and cancer have been linked in animal trials.
According to Agriculture.com, Chuck Benbrook, the project coordinator for Heartland Study, a group that researches herbicides and their effects on humans, said he was “flabbergasted” at the EPA’s decision to do nothing “to reduce worker exposures and risks.”
Benbrook’s statement said he could not understand why the EPA at the very least did not require labels that indicated workers wear gloves, long sleeves, long pants and rubber boots to safely mix and apply glyphosate-based herbicides.
Roundup is made by Monsanto, which was bought out by Bayer AG in June 2018.
Roundup and Cancer Lawsuits
On Feb. 3, St. Louis City Circuit Court Judge Elizabeth Hogan issued a notification that a Roundup cancer trial there would not open on Feb. 5 as planned. According to USRTK.org, Monsanto could be attempting to negotiate a worldwide settlement in tens of thousands of lawsuits, most of which have been filed by cancer victims or their surviving families.
The St. Louis case includes four plaintiffs who allege either they or a loved one were diagnosed with non-Hodgkin’s lymphoma due to exposure to glyphosate herbicides.
According to USRTK.org, Bayer may pay $10 billion to settle most or all of the claims against Monsanto’s Roundup products.
Despite the EPA’s insistence that glyphosate-based weed killers are safe as long as the label directions are followed, researchers who performed a meta-analysis of glyphosate data determined there was a “compelling link” between glyphosate and cancer, particularly non-Hodgkin’s lymphoma. According to MotherJones.com, the study stated that workers exposed to glyphosate on a regular basis have more than a 40 percent higher risk of developing non-Hodgkin’s lymphoma compared to people who don’t use the chemical.
Three of the researchers who co-authored the study previously worked on the EPA Scientific Advisory Panel that assessed glyphosate back in 2016. At that time, the 15-member committee was not in agreement as to whether or not glyphosate was a carcinogen, but the EPA eventually determined it was not.
Non-Hodgkin’s lymphoma is a cancer that begins in the white blood cells, which are medically known as lymphocytes. The immune system depends on white blood cells to protect the body against disease and infection. The body’s lymphatic system is part of the immune system that helps move fluids through the body, helping push bacteria and cell waste out of the body.
If you or a loved one developed cancer after using Roundup as a farm worker or home gardener, you may have a legal claim. Legal migrant farm workers may also seek help. Learn more by filling out the form on this page for a FREE case evaluation.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2024 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
Get Help – It’s Free
Join a Free Roundup Cancer Class Action Lawsuit Investigation
For the most up-to-date information on this case, click here.